Atrial fibrillation (AF) – the most common rhythm disturbance, the frequency of which increases with age, the presence of mitral
valve disease and combined them together. Related AF hemodynamic deterioration, increased incidence of thromboembolic events
may lead to disability population, death and great financial expenses for the treatment of patients.
Maze procedure for the treatment of atrial fibrillation in conjunction with the correction of mitral valve disease is an effective method
of restoring sinus rhythm and the elimination of valve dysfunction on the results of early and long-term follow-up period.
In the present we have the clinical description was performed surgery to remove a complex heart disease: performed mitral valve
replacement, tricuspid valve and plastic Maze procedure. It is important to note that it was the second operation in a patient with high
intraoperative risk due to a long history of atrial fibrillation, atrial large size. In this case, the operation of choice was the Maze procedure
with a prosthetic mitral valve and tricuspid valve plasty. I would like to draw the attention of clinicians that the patient is sufficiently
addressed later surgical treatment. Despite all the difficulties, the patient successfully completed the operation, the result of
the correct indications and, most importantly, a radical correction of cardiac pathologies and the valve and AF. The case study of the
clinical application of the Maze procedure with prosthetic mitral valve, tricuspid valve plasty shows its high efficiency in the removal
of AF, as well as good compatibility with the operation of correcting defects of the mitral and tricuspid valves. Our observation suggests
the existence of sufficient capacity for cardiac surgeon in achieving optimum results for the correction of defects of the heart
valves in combination with AF, including the long-term persistent AF.
- Бокерия Л.А., Полунина А.Г., Лефтерова Н.П., Булаева Н.И., Голухова Е.З. Фибрилляция предсердий, дилатация левых камер сердца: пусковые механизмы развития
когнитивных нарушений у кардиологических больных.
Креативная кардиология. 2015; 1: 38–45. / Bockeria L.A.,
Polunina A.G., Lefterova N.P., Bulaeva N.I., Golukhova E.Z.
Atrial fibrillation, dilatation of the left chambers of heart: starting
mechanisms of cognitive disturbances of cardiac patients.
Kreativnaya kardiologiya. 2015; 1: 38–45 (in Russ.).
- Sherman D.G., Hart R.G., Easton J.D. The secondary prevention
of stroke in patients with atrial fibrillation. Arch. Neurol.
1986; 43: 68–70.
- Alpert J.S., Peterson P., Godtfredsen J. Atrial fibrillation: natural
history, complications and management. Ann. Rev. Med.
1988; 39: 41–52.
- Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M.
Epidemiologie features of chronic atrial fibrillation. The
Framingham study. N. Engl. J. Med. 1982; 306 (17):
- Wolf P.A., Dawber T.R., Thomas H.E., Kannel W.B. Epidemiologic
assessment of chronic atrial fibrillation and a risk of
stroke. The Framingham study. Neurology. 1978; 28: 973–7.
- Бокерия Л.А., Ревишвили А.Ш., Муратов Р.М. и др. Опыт
хирургического лечения фибрилляции предсердий в сочетании с коррекцией порока митрального клапана. Грудная
и сердечно-сосудистая хирургия. 2003; 6: 12–8. /
Bockeria L.A., Revishvili A.Sh., Muratov R.M. et al. Experience
surgical treatment for atrial fibrillation in combination with
the mitral valve correction. Grudnaya i serdechno-sosudistaya
khirurgiya. 2003; 6: 12–8 (in Russ.).
- Fuster V., Ryden L.E., Asinger R.W. et al. ACC/AHA/ESC
guidelines for the management of patients with atrial fibrillation;
executive summary. J. Am. Coll. Cardiol. 2001; 38: 1231–66.